SUFLAVE FDA approval date
The FDA approved SUFLAVE on 15 Jun 2023.
- FDA approval date
- 15 Jun 2023
- Source
- FDA record
Drug identity has not yet been verified against registry records
Also recorded as MAGNESIUM SULFATE; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM SULFATE
Included trials
No linked trials for this drug yet. Browse all trials
PDUFA dates and FDA decisions
| Date as reported | Drug / company | Event | Condition | Evidence |
|---|---|---|---|---|
| 2023-06-15Day | SUFLAVE | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA215344", "applicant_as_listed_by_fda": "AZURITY", "brand_names": ["SUFLAVE"], "active_ingredients": ["MAGNESIUM SULFATE", "POLYETHYLENE GLYCOL 3350", "POTASSIUM CHLORIDE", "SODIUM CHLORIDE", "SODIUM SULFATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20230615", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |